a developer of cell based immune therapeutics and vaccines for cancer treatment
Industry Biotechnology
A.I.dvisor indicates that over the last year, MRKR has been loosely correlated with CGTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MRKR jumps, then CGTX could also see price increases.
Ticker / NAME | Correlation To MRKR | 1D Price Change % | ||
---|---|---|---|---|
MRKR | 100% | -3.85% | ||
CGTX - MRKR | 36% Loosely correlated | -4.75% | ||
INTS - MRKR | 27% Poorly correlated | +2.42% | ||
UNCY - MRKR | 27% Poorly correlated | -6.30% | ||
TSVT - MRKR | 26% Poorly correlated | -5.08% | ||
ADTX - MRKR | 25% Poorly correlated | +0.17% | ||
More |
Ticker / NAME | Correlation To MRKR | 1D Price Change % |
---|---|---|
MRKR | 100% | -3.85% |
cancer theme (82 stocks) | 21% Poorly correlated | -2.35% |
immune theme (11 stocks) | 16% Poorly correlated | -3.03% |
personal theme (71 stocks) | 9% Poorly correlated | -0.66% |
consumer services theme (40 stocks) | 8% Poorly correlated | -1.18% |
vaccines theme (15 stocks) | 3% Poorly correlated | -5.06% |